FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival

ABSTRACT Background FXYD3 is a Na/K‐ATPase modulator which is upregulated in pancreatic ductal adenocarcinoma (PDAC), but its prognostic role is unknown. This study evaluated FXYD3 expression in chemo‐naive patients with surgically‐resected PDAC at a single centre (1993–2014). Method FXYD3 expressio...

Description complète

Détails bibliographiques

Auteurs principaux:	Nathalie B. Rasko, Christopher B. Nahm, John Turchini, Rachel Teh, Helge Rasmussen, Sooin Byeon, Sumit Sahni, Jaswinder S. Samra, Anthony J. Gill, Anubhav Mittal
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2025-01-01
Collection:	Cancer Medicine
Sujets:	FXYD3 MAT‐8 pancreatic cancer pancreatic ductal adenocarcinoma prognosis survival
Accès en ligne:	https://doi.org/10.1002/cam4.70500
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!